文献速递前列腺癌

体重管理对肥胖驱动的前列腺癌进展生物标志物的影响

Impact of Weight Management on Obesity-Driven Biomarkers of Prostate Cancer Progression.
PubMed 文献 · J Urol · 2024-02-01

这项II期研究将40名拟行前列腺切除术的男性随机分为干预组(n=20)和对照组(n=20),干预组在术前4至16周及术后6个月接受体重管理项目。从基线到手术(平均5周),干预组体重减轻5.5%(95%CI,4%-7%),并降低了胰岛素、总胆固醇、LDL胆固醇、瘦素、瘦素与脂联素比值及内脏脂肪组织;前列腺组织标志物无显著变化。

要点

  • 干预组从基线到手术(平均5周)体重减轻5.5%(95%CI,4%-7%)。
  • 干预组较对照组降低了胰岛素、总胆固醇、LDL胆固醇、瘦素、瘦素与脂联素比值及内脏脂肪组织。
  • 干预组前列腺组织标志物无显著变化,髓源性抑制细胞组间无统计学差异。

核心结论

  • 本研究表明体重管理干预改善了身体成分、前列腺癌生物标志物和生活质量。

研究设计与样本

  • 这项II期研究将40名拟行前列腺切除术的男性随机分为干预组(n=20)和对照组(n=20)。
  • 干预组在术前4至16周及术后6个月接受体重管理项目,对照组接受标准化教育材料。
  • 所有参与者在基线、术前1周及术后6个月进行随访,评估循环免疫细胞、细胞因子和趋化因子,并分析活检和手术获取的前列腺组织样本。

主要发现

  • 从基线到手术(平均5周),干预组体重减轻5.5%(95%CI,4%-7%)。
  • 与对照组相比,干预组还降低了胰岛素、总胆固醇、LDL胆固醇、瘦素、瘦素与脂联素比值及内脏脂肪组织。
  • 干预组从基线到手术降低了C肽、纤溶酶原激活物抑制剂-1和T细胞计数。
  • 髓源性抑制细胞组间无统计学差异,前列腺组织标志物无显著变化。
  • 干预组一般健康和情绪健康的生活质量指标改善,研究结束时维持或继续减重至初始体重的净减少11%(95%CI,8%-14%)。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Excess body and visceral fat increase the risk of death from prostate cancer (PCa). This phase II study aimed to test whether weight reduction by > 5% total body weight counteracts obesity-driven PCa biomarkers. MATERIALS AND METHODS: Forty men scheduled for prostatectomy were randomized into intervention (n = 20) or control (n = 20) arms. Intervention participants followed a weight management program for 4 to 16 weeks before and 6 months after surgery. Control participants received standardized educational materials. All participants attended visits at baseline, 1 week before surgery, and 6 months after surgery. Circulating immune cells, cytokines, and chemokines were evaluated. Weight loss, body composition/distribution, quality of life, and nutrition literacy were assessed. Prostate tissue samples obtained from biopsy and surgery were analyzed. RESULTS: From baseline to surgery (mean = 5 weeks), the intervention group achieved 5.5% of weight loss (95% CI, 4%-7%). Compared to the control, the intervention also reduced insulin, total cholesterol, LDL cholesterol, leptin, leptin:adiponectin ratio, and visceral adipose tissue. The intervention group had reduced c-peptide, plasminogen-activator-inhibitor-1, and T cell count from baseline to surgery. Myeloid-derived suppressor cells were not statistically different by group. Intervention group anthropometrics improved, including visceral and overall fat loss. No prostate tissue markers changed significantly. Quality of life measures of general and emotional health improved in the intervention group. The intervention group maintained or kept losing to a net loss of 11% initial body weight (95% CI, 8%-14%) at the study end. CONCLUSIONS: Our study demonstrated improvements in body composition, PCa biomarkers, and quality of life with a weight management intervention.

来源:J Urol,查看原文。版权归原作者所有。

引用

  1. Bechtel MD, Michel C, Srinivasan P, et al. Impact of Weight Management on Obesity-Driven Biomarkers of Prostate Cancer Progression. J Urol. 2024. PMID: 38299570. doi:10.1097/JU.0000000000003849

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。